In this study, we tried to fill this gap by carrying out DNA methylation analysis of SFRP2 and DKK1 promoter regions, using a series of biopsies obtained from HCV infected CH and LC patients. This evidence concerns the gene SFRP2 and cyclic hematopoiesis.